Genetic diagnosis of 21-hydroxylase deficiency: DGGE-based mutation scanning of CYP21

Human Mutation

Volumn 13, Issue 5, 1999, Pages 385-389

  Ohlsson, Gita ^a,b   Müller, Jørn ^a   Schwartz, Marianne ^a  

^a Rigshospitalet   (Denmark)

^b Rigshopitalet 4062 ^*  (Denmark)

Author keywords

Congenital adrenal hyperplasia; CYP21; DGGE; Mutation detection; Steroid 21 hydroxylase

Indexed keywords

STEROID 21 MONOOXYGENASE;

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; GENE DELETION; GENETIC ANALYSIS; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; CYTOCHROME P-450 CYP2B1; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; ELECTROPHORESIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION;

EID: 0344326345     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(1999)13:5<385::AID-HUMU7>3.0.CO;2-2     Document Type: Article

References (28)

1. Barbat B, Bogyo A, Raux-Demay MC, Kuttenn F, Boue J, Simon-Bouy B, Serre JL, Mornet E. 1995. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat 5:126-130.
2. Cicognani A. 1992. The experience of neonatal screening for congenital adrenal hyperplasia. Horm Res 37(suppl 3):34-38.
3. Condie A, Eeles R, Borresen AL, Coles C, Cooper C, Prosser J. 1993. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mutat 2:58-66.
4. Ezquieta B, Oliver A, Gracia R, Gancedo PG. 1995. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet 96:198-204.
5. Guldberg P, Guttler F. 1993. A simple method for identification of point mutations using denaturing gradient gel electrophoresis. Nucleic Acids Res 21:2261-2262.
6. Kirby Keyser L, Porter CC, Donohoue PA. 1997. E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Mutat 9:181-182.
7. Kuipers OP, Boot HJ, de Vos WM. 1991. Improved site-directed mutagenesis method using PCR. Nucleic Acids Res 19:4558.
8. Lajic S, Wedell A. 1996. An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia. Hum Genet 98:182-184.
9. Lajic S, Levo A, Nikoshkov A, Lundberg Y, Partanen J, Wedell A. 1997. A cluster of missense mutations at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction. Hum Genet 99:704-709.
10. Landt O, Grunert HP, Hahn U. 1990. A general method for rapid site-directed mutagenesis using the polymerase chain reaction. Gene 96:125-128.
11. Lerman LS, Silverstein K. 1987. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 155:482-501.
12. Levo A, Partanen J. 1997. Novel nonsense mutation (W302X) in the steroid 21-hydroxylase gene of a Finnish patient with the salt-wasting form of congenital adrenal hyperplasia. Hum Mutat 9:363-365.
13. Lobe TE, Woodall DL, Richards GE, Cavallo A, Meyer WJ. 1987. The complications of surgery for intersex: changing patterns over two decades. J Pediatr Surg 22:651-652.
14. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
15. Moyret C, Theiller C, Puig PL, Moles JP, Thomas G, Hamelin R. 1994. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 9:1739-1743.
16. Myers RM, Maniatis T, Lerman, LS. 1987. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501-527.
17. Ohlsson G, Schwartz M. 1997. Mutations in the gene encoding 21-hydroxylase detected by solid-phase minisequencing. Hum Genet 99:98-102.
18. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S. 1988. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81:866-874.
19. Sheffield VC, Cox DR, Lerman LS, Myers RM. 1989. Attachment of a 40-base-pair G + C-rich sequence (GC clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci USA 86:232-236.
20. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. 1985. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650-667.
21. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie Luna MT, Lesser M, New MI, White PC. 1992. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584-595.
22. Strachan T. 1990. Molecular pathology of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 32:373-393.
23. Tusie Luna MT, White PC. 1995. Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci USA 92:10796-10800.
24. Wedell A, Chun X, Luthman H. 1994a. A steroid 21-hydroxylase allele concomitantly carrying four disease-causing mutations is not uncommon in the swedish population. Hum Genet 93:204-206.
25. Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H. 1994b. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145-1152.
26. Wedell A, Luthman H. 1993. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum Mol Genet 2:499-504.
27. White PC, New MI, Dupont B. 1987. Congenital adrenal hyperplasia. 1. N Engl J Med 316:1519-1524.
28. White PC. 1989. Analysis of mutations causing steroid 21-hydroxylase deficiency. Endocr Res 15:239-256.